Cemented TrendHip® - Multicenter PMCF Study on Total Indications

Last updated: March 12, 2025
Sponsor: Aesculap AG
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Rheumatoid Arthritis

Osteoporosis

Dermatomyositis (Connective Tissue Disease)

Treatment

Total Hip Arthroplasty

Clinical Study ID

NCT04943328
AAG-O-H-2105
  • Ages > 18
  • All Genders

Study Summary

This Post Market Clinical Follow-Up (PMCF) study to evaluate the performance and safety of the cemented TrendHip® stem in a prospective follow-up study with patients who underwent a hip arthroplasty with the investigational product (representative of usual clinical practice), at two follow-up examinations

Eligibility Criteria

Inclusion

Inclusion: Inclusion criteria

  • Patient older than 18 years.

  • Patient who undergo / underwent a hip arthroplasty with cemented TrendHip® femoral stem according to the indications for implantation specified in the Instructions for Use.

  • Patient not opposing participation in the study.

Exclusion: Exclusion criteria

  • Patient with shortened life expectancy.

  • The patient is unable to commit to the planned follow-up period.

Study Design

Total Participants: 122
Treatment Group(s): 1
Primary Treatment: Total Hip Arthroplasty
Phase:
Study Start date:
February 23, 2021
Estimated Completion Date:
May 08, 2028

Connect with a study center

  • St. Franziskus-Hospital

    Ahlen, Nordrhein-Westfalen 59227
    Germany

    Site Not Available

  • St. Vincenz Hospital Brakel

    Brakel, 33034
    Germany

    Site Not Available

  • St.-Josefs-Hospital

    Dortmund, 44263
    Germany

    Site Not Available

  • St. Marien-Hospital

    Mülheim an der Ruhr, 45468
    Germany

    Site Not Available

  • radprax Krankenhaus Plettenberg GmbH

    Plettenberg, 58840
    Germany

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.